Progress happens everyday at Octane

Here’s what’s new

Octane Completes Major Expansion of State-of-the-Art Facility in Kingston, Ontario
Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada. The 40,000-square-foot building, which Octane purchased in 2011, houses the company's head office and features regulated biolabs for biomaterial and biologics discovery programs including cell therapy research and development, a ...
Read More
Octane Wins 2020 Edison Award in Cellular Research for AUTOGRAFTA™ Synthesis of Living Grafts for Skeletal Reconstruction
Maine, USA, 18 March 2020 – Octane innovations in tissue engineering, personalized medicine and automated living implant production have earned one of the highest Edison Awards, winning Gold in the Medical / Dental Cellular Research category. The Gold award recognizes AUTOGRAFTA™ living graft technology and the ability to ...
Read More
Lonza Acquires a Controlling Stake in Octane Biotech to Further Develop Cocoon™ Autologous Technology
Basel, Switzerland, 29 October 2018 – Lonza announced today the acquisition of a controlling stake in Octane Biotech, with the right to acquire full ownership. The increase in equity share will allow Lonza to further develop the technology to support the growing need for scalable autologous manufacturing. Octane ...
Read More
Octane’s Cocoon Technology Wins Prestigious iF Design Award
Hannover, Germany, 09 March 2018 – iF International Forum Design GmbH has recognized Octane’s Cocoon technology with this year’s iF Design Award for best product – a tremendous honour from one of the world’s most celebrated and valued design competitions, with more than 6,000 submissions each year from ...
Read More
Cocoon Wins Silver in Spark Design Awards
New York, November 20, 2017 - Octane’s Cocoon automated bioreactor is this year’s recipient of the Silver prize in the Health category of the Spark Design Awards, an 11-year-old competition that recognizes modern designs which innovate, change the game and, in some way, help humanity or the environment ...
Read More
Octane and Lonza Announce Exclusive Collaboration to Evaluate Groundbreaking Autologous Cell Therapy Technology
Basel, Switzerland, and Ontario, Canada, 23 June 2015 – Lonza Group Ltd. in Switzerland and Octane Biotech Inc. in Canada have agreed to enter into an exclusive technology evaluation of the Cocoon™ cell production platform for personalized cell therapy manufacturing with the goal of a global deployment of ...
Read More
Octane and Jubilant forge partnership to launch the most advanced radioisotope delivery system for PET imaging
Kingston, Ontario, October 2014 – Octane Medical Group has established a collaboration with Jubilant DraxImage Inc., a subsidiary of the multinational Jubilant Life Sciences in Uttar Pradesh, India, to develop and produce radioisotope patient infusion lines for RUBY-FILL, the most advanced Positron Emission Tomography (PET) delivery system for ...
Read More
Octane joins forces with Aesculap to advance living-tissue orthopedic implants into clinical use
Kingston, Ontario, May 2012 – Octane Medical Group has entered into a partnership with Aesculap Biologics, LLC, a subsidiary of the multinational Aesculap Inc., (a B. Braun company) one of the world’s largest orthopedic companies with a focus on innovative spine and orthopedic treatments. The partnership is an ...
Read More